In vitroinhibitory effects of non‐steroidal anti‐inflammatory drugs on 4‐methylumbelliferone glucuronidation in recombinant human UDP‐glucuronosyltransferase 1A9—potent inhibition by niflumic acid
Authors:
- 9 November 2005
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 27 (1) , 1-6
Abstract
The inhibitory potencies of non‐steroidal anti‐inflammatory drugs (NSAIDs) on UDP‐glucuronosyltransferase (UGT) 1A9 activity were investigated in recombinant human UGT1A9 using 4‐methylumbelliferone (4‐MU) as a substrate for glucuronidation. 4‐MU glucuronidation (4‐MUG) showed Michaelis‐Menten kinetics with aKmvalue of 6.7 µM. The inhibitory effects of the following seven NSAIDs were investigated: acetaminophen, diclofenac, diflunisal, indomethacin, ketoprofen, naproxen and niflumic acid. Niflumic acid had the most potent inhibitory effect on 4‐MUG with an IC50value of 0.0341 µM. The IC50values of diflunisal, diclofenac and indomethacin were 1.31, 24.2, and 34.1 µM, respectively, while acetaminophen, ketoprofen and naproxen showed less potent inhibition. Niflumic acid, diflunisal, diclofenac and indomethacin inhibited 4‐MUG competitively withKivalues of 0.0275, 0.710, 53.3 and 69.9 µM, respectively, being similar to each IC50value. In conclusion, of the seven NSAIDs investigated, niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4‐MUG in a competitive manner. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Effects of?-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9Biopharmaceutics & Drug Disposition, 2004
- Identification of common polymorphisms in the promoter of the UGT1A9 genePharmacogenetics, 2004
- Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoformsArchives of Biochemistry and Biophysics, 2004
- Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7Xenobiotica, 2003
- Characterization of bropirimineO-glucuronidation in human liver microsomesXenobiotica, 2003
- In Vitro Characterization of Hepatic Flavopiridol Metabolism Using Human Liver Microsomes and Recombinant UGT EnzymesPharmaceutical Research, 2002
- Characterization of Rat and Human UDP-Glucuronosyltransferases Responsible for the in Vitro Glucuronidation of DiclofenacToxicological Sciences, 2001
- Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecinXenobiotica, 2001
- Expression of the UDP-glucuronosyltransferase 1A Locus in Human ColonJournal of Biological Chemistry, 1998
- Drug glucuronidation in humansPharmacology & Therapeutics, 1991